Third Point Capital built a stake in Johnson & Johnson (JNJ) spinoff Kenvue (KVUE), the Financial Times reported Friday, citing people familiar with the matter.
Pressure on Kenvue's management may be increasing as activist investors focus on the consumer health group, spurring speculation that the company might be a takeover target, the report said.
Hedge fund Toms Capital Investment Management also built a stake in Kenvue, calling for a sale or breakup of the company, other people familiar with the matter said.
Kenvue and Toms didn't immediately respond to requests for comment. and Third Point declined to comment, the Financial Times said.
Kenvue and Third Point didn't immediately respond to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 154.19, Change: -0.75, Percent Change: -0.48
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.